Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke

  • Puig, Josep
  • Blasco, Gerard
  • Daunis-i-Estadella, Pepus
  • van Eendenburg, Cecile
  • Carrillo-García, María
  • Aboud, Carlos
  • Hernández-Pérez, María
  • Serena, Joaquín
  • Biarnés, Carles
  • Nael, Kambiz
  • Liebeskind, David S.
  • Thomalla, Götz
  • Menon, Bijoy K.
  • Demchuk, Andrew M.
  • Wintermark, Max
  • Pedraza, Salvador
  • Castellanos, María del Mar
[Abstract] Objective: Blood-brain barrier (BBB) permeability has been proposed as a predictor of hemorrhagic transformation (HT) after tissue plasminogen activator (tPA) administration; however, the reliability of perfusion computed tomography (PCT) permeability imaging for predicting HT is uncertain. We aimed to determine the performance of high-permeability region size on PCT (HPrs-PCT) in predicting HT after intravenous tPA administration in patients with acute stroke. Methods: We performed a multimodal CT protocol (non-contrast CT, PCT, CT angiography) to prospectively study patients with middle cerebral artery occlusion treated with tPA within 4.5 hours of symptom onset. HT was graded at 24 hours using the European-Australasian Acute Stroke Study II criteria. ROC curves selected optimal volume threshold, and multivariate logistic regression analysis identified predictors of HT. Results: The study included 156 patients (50% male, median age 75.5 years). Thirty-seven (23,7%) developed HT [12 (7,7%), parenchymal hematoma type 2 (PH-2)]. At admission, patients with HT had lower platelet values, higher NIHSS scores, increased ischemic lesion volumes, larger HPrs-PCT, and poorer collateral status. The negative predictive value of HPrs-PCT at a threshold of 7mL/100g/min was 0.84 for HT and 0.93 for PH-2. The multiple regression analysis selected HPrs-PCT at 7mL/100g/min combined with platelets and baseline NIHSS score as the best model for predicting HT (AUC 0.77). HPrs-PCT at 7mL/100g/min was the only independent predictor of PH-2 (OR 1, AUC 0.68, p = 0.045). Conclusions: HPrs-PCT can help predict HT after tPA, and is particularly useful in identifying patients at low risk of developing HT., This work was partially supported by grants from the Spanish Ministry of Health, Instituto de Investigación Carlos III (PI10/01309 and PI13/02258), the ERDF: European Regional Development Fund and the Spanish Stroke Research Network (INVICTUS), also financed by the Instituto de Salud Carlos III (RD12/0014/0001 and RD16/0019/0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Low levels of caveolin-1 predict symptomatic bleeding after thrombolytic therapy in patients with acute ischemic stroke

  • Castellanos, María del Mar
  • van Eendenburg, Cecile
  • Gubern, Carme
  • Kádár, Elisabet
  • Huguet, Gemma
  • Puig, Josep
  • Sobrino, Tomás
  • Blasco, Gerard
  • Serena, Joaquín
  • Sánchez, Juan Manuel
[Abstract] Background and purpose: Experimental models of cerebral ischemia demonstrate that the decrease in the caveolin-1 membrane protein results in an increase in endothelial permeability. Because this phenomenon is responsible for hemorrhagic transformation (HT) after cerebral ischemia, we aimed to determine whether caveolin-1 levels may predict bleeding after recombinant tissue-type plasminogen activator (r-tPA) administration in patients with acute stroke. Methods: We studied 133 patients with a first hemispheric stroke treated with r-tPA within 4.5 hours of symptom onset. HT was evaluated and classified on cranial computed tomography at 24 hours and was considered as symptomatic HT (sHT) if associated with neurological deterioration. Serum caveolin-1 levels were analyzed before and at 2, 24, and 72 hours post-r-tPA administration in patients and in 40 healthy controls. Results: Baseline caveolin-1 levels were higher in patients than controls (0.24 [0.17-0.40] versus 0.07 [0.0-0.20] ng/mL; P<0.000). Twenty six (19.5%) patients had HT, which was symptomatic in 7 (5.3%). Patients with parenchymal hemorrhage-2 and sHT had lower baseline caveolin-1 levels than the rest of patients (0.08 [0.04-0.19] versus 0.26 [0.14-0.40]; P=0.019 and 0.08 [0.02-0.17] versus 0.26 [0.13-0.41]; P=0.019, respectively). The levels remained stable in the first 72 hours in patients with parenchymal hemorrhage-2 and sHT, whereas in the rest of patients levels decreased in this time. Caveolin-1 levels ≤0.17 ng/mL had the highest predictive capacity of sHT (86% sensitivity, 65% specificity, 99% negative predictive value, 12% positive predictive value). After adjustment for confounders, caveolin-1 levels ≤0.17 ng/mL independently predicted sHT (odds ratio, 11.6; 95% confidence interval, 11.3-102.8; P=0.027). Conclusions: Low serum levels of caveolin-1 are an independent predictor of sHT after r-tPA administration. Because of the small sample size, further research is needed to validate these data., This study has been supported by the Health Strategic Action Program(PI10/01309 and PI13/02258) of the Instituto de Salud Carlos III(ISCIII), the European Regional Development Fund, and the SpanishStroke Research Network (INVICTUS and INVICTUS-PLUS). DrSobrino (CPII17/00027) is the recipient of a research contract fromthe ISCIII, Miguel Servet II Program.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Evaluation of common housekeeping proteins under ischemic conditions and/or rt-PA treatment in bEnd.3 cells

  • Comajoan, Pau
  • Gubern, Carme
  • Huguet, Gemma
  • Serena, Joaquín
  • Kádár, Elisabet
  • Castellanos, María del Mar
[Abstract] Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is the only pharmacological approved treatment for ischemic stroke, despite its associated increasing risk of hemorrhagic transformation. Since many of rt-PA effects in blood-brain barrier (BBB) are not well characterized, the study of protein changes in BBB cells after rt-PA administration may help to understand its adverse effects. Our aim was to analyze protein levels of four commonly used housekeeping proteins: β-Actin, α-Tubulin, GAPDH and HPRT in bEnd.3 endothelial cell line subjected to oxygen and glucose deprivation (OGD) conditions and rt-PA treatment to determine their reliability as Western blot loading controls. bEnd.3 monolayers were subjected to 2.5 h of OGD and reperfusion with/without 20 μg/ml of rt-PA. At 3, 6, 24 and 72 h post-OGD, protein levels were analyzed by Western blot using Stain-Free technology. OGD significantly decreased β-Actin, α-Tubulin, GAPDH and HPRT protein levels at 3, 6, 24 and 72 h post-OGD without significant rt-PA treatment effects except for the GAPDH levels increase in control condition at 3 h post-OGD. The present study clearly demonstrated that β-Actin, α-Tubulin, GAPDH and HPRT proteins are not suitable as loading controls for Western Blot analysis in bEnd.3 cells after OGD. Significance: We reported altered levels of β-Actin, α-Tubulin, GAPDH and HPRT housekeeping proteins in bEnd.3 endothelial cell line after an ischemic insult. Therefore, we demonstrated that these proteins are not suitable as loading controls for Western Blot analysis in our experimental conditions and we recommended the use of Stain-Free gels as an alternative to traditional housekeeping proteins normalization., This research has been supported by the Instituto de Salud Carlos III, Health Strategic Action Program (PI13/02258) and the Spanish Stroke Research Network (RD16/0019/003) (INVICTUS and INVICTUS-PLUS). We also gratefully acknowledge grant support from Universitat de Girona (MPCUdG2016/092). P. Comajoan is supported by a predoctoral fellowship from University of Girona.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke

  • Puig, Josep|||0000-0003-2791-6599
  • Blasco, Gerard|||0000-0002-5302-0625
  • Daunis-i-Estadella, Pepus|||0000-0001-6134-9255
  • Eendendburg, Cecile van
  • Carrillo-García, María
  • Aboud, Carlos
  • Hernández-Pérez, María|||0000-0001-8279-7954
  • Serena, Joaquín|||0000-0002-4478-7744
  • Biarnés, Carles|||0000-0002-6604-2014
  • Nael, Kambiz
  • Liebeskind, David S.|||0000-0002-5109-8736
  • Thomalla, Götz
  • Menon, Bijoy K.
  • Demchuk, Andrew
  • Wintermark, Max
  • Pedraza, Salvador
  • Castellanos, María del Mar|||0000-0003-3116-1352
Objective. Blood-brain barrier (BBB) permeability has been proposed as a predictor of hemorrhagic transformation (HT) after tissue plasminogen activator (tPA) administration; however, the reliability of perfusion computed tomography (PCT) permeability imaging for predicting HT is uncertain. We aimed to determine the performance of high-permeability region size on PCT (HPrs- PCT) in predicting HT after intravenous tPA administration in patients with acute stroke. Methods. We performed a multimodal CT protocol (non-contrast CT, PCT, CT angiography) to prospectively study patients with middle cerebral artery occlusion treated with tPA within 4.5 hours of symptom onset. HT was graded at 24 hours using the European-Australasian Acute Stroke Study II criteria. ROC curves selected optimal volume threshold, and multivariate logistic regression analysis identified predictors of HT. Results. The study included 156 patients (50% male, median age 75.5 years). Thirty-seven (23,7%) developed HT [12 (7,7%), parenchymal hematoma type 2 (PH-2)]. At admission, patients with HT had lower platelet values, higher NIHSS scores, increased ischemic lesion volumes,larger HPrs-PCT, and poorer collateral status. The negative predictive value of HPrs-PCT at a threshold of 7mL/100g/min was 0.84 for HT and 0.93 for PH-2. The multiple regression analysis selected HPrs-PCT at 7mL/100g/min combined with platelets and baseline NIHSS score as the best model for predicting HT (AUC 0.77). HPrs-PCT at 7mL/100g/min was the only independent predictor of PH-2 (OR 1, AUC 0.68, p = 0.045). Conclusions. HPrs-PCT can help predict HT after tPA, and is particularly useful in identifying patients at low risk of developing HT.